RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024.

In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0. This was 17 months after the release of RayCare 5B. The interoperability certificate for 2024A that was issued now comes already before the release of RayCare 2024A which is scheduled to be finalized in a few weeks from now.

TrueBeam is Varian’s most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements. The interoperability certificate applies to linacs in the TrueBeam family equipped with kV imaging: TrueBeam, TrueBeam STx, Edge and VitalBeam.

Agam Sharda, VP of Product & Portfolio Management at Varian, says: “By achieving clinical interoperability between TrueBeam and RayCare, Varian again shows our commitment to developing, deploying, and maintaining critical interfaces for our fleet to operate seamlessly. RaySearch as an alliance in our ecosystem program is another example of our resolve to meet the diverse needs of customers across the world.”

Johan Löf, founder and CEO, RaySearch, says: “Interoperability with treatment delivery systems is a key feature of RayCare and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release and I look forward to clinical implementation of the connection later in 2024.”   

* Subject to regulatory clearance in some markets.

For more information: www.raysearchlabs.com


Related Content

News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
News | Radiation Therapy

Aug. 13, 2026 — An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence ...

Time August 17, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Innovative Hospitals

July 27, 2026 — Vanderbilt Health and Siemens Healthineers have entered into a multi-year, $87 million Value ...

Time July 28, 2026
arrow
News | ASTRO

July 22, 2026 — The American Society for Radiation Oncology (ASTRO) has announced the 39 members who will receive the ...

Time July 23, 2026
arrow
News | Radiation Therapy

June 3, 2026 — Alpha Tau Medical Ltd. and Tolmar International Ltd. have announced a strategic collaboration agreement ...

Time June 04, 2026
arrow
News | ASTRO

May 18, 2026 — The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and ...

Time May 19, 2026
arrow
Subscribe Now